Companies
RSSL
RSSL (Reading, UK) runs dedicated Qualified Person, GMP Master Series and process-validation courses, such as a 2-day Process Validation programme (June 3-4, 2026) aligning FDA, EU GMP, MHRA and WHO lifecycle expectations.
- Country
- United Kingdom
Commercial
QP / GMP Training
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| education-workforce | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | No public equity funding rounds (Seed, Series A-C) identified; company is a wholly owned subsidiary of Mondelēz International. | biobase.whitefordresearch.com |
| Capacity | New analytical testing facility provides 26,000 sq. ft. of additional working laboratory space. | rssl.com |
| Certification | UKAS Accredited Testing Laboratory (No 1216) and BS EN ISO/IEC 17025:2017 compliant. | rssl.com |
| Regulatory approval | MHRA Certificate of GMP Compliance for human and veterinary medicinal products; US FDA classified as an acceptable contract testing laboratory. | rssl.com |
| Production site | Reading Science Centre (Whiteknights Campus, Reading, UK). | rssl.com |
| Headcount | 357 employees (as of 2024-12-31). | theaccounts.uk · rssl.com |
| Revenue | £36,736,000 (turnover for the year ending 2024-12-31). | theaccounts.uk |
Independent sources: biobase.whitefordresearch.com · theaccounts.uk
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Corporate GMP/GLP/GCP training | education-workforce | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.